Lacticaseibacillus paracasei JY062 Postbiotic Alleviated 3% DSS-Induced Colitis in Mice via Integrated Antioxidant, Barrier Repair, Immunomodulatory and Microbiota Modulation
Antioxidants · 2025-10-19 · 14 (10) · 1256
DOI: 10.3390/antiox14101256 ↗At a glance
Journal article in Antioxidants, published online on 2025-10-19. Written by Jinfeng Guo and 7 co-authors. Institution: Key Laboratory of Dairy Science, Ministry of Education, College of Food Science, Northeast Agricultural University, Harbin 150031, China. Cited 9 times so far (Crossref); 102 references. The full text is freely available (open access, CC BY 4.0). Funded by: This research received financial backing from the Heilongjiang Provincial Natural Science Foun-dation Project, Heilongjiang Provincial Natural Science Foundation Project.
Abstract (original language)
Ulcerative colitis (UC) with multifactorial etiology remains clinically challenging. While current pharmacotherapies alleviate symptoms, their long-term application is constrained by significant side effects. Lacticaseibacillus paracasei JY062 postbiotic (Pa JY062) exerts multi-target therapeutic effects via integrated antioxidant, barrier repair, immunomodulatory and microbiota modulation for UC. Pa JY062 exhibited potent antioxidant capacity and reduced reactive oxygen species (ROS) in Caco-2 cells. In DSS-colitis mice, high-dose Pa JY062 (HP, 800 mg/kg) restored intestinal barrier integrity (Evans blue permeability: 0.0547 vs. 0.107, p < 0.01), enhanced antioxidant defenses (SOD: 9.43 vs. 5.5; GSH-Px: 62.74 vs. 40.94 U/mg protein, p < 0.01), and rebalanced Th1/Th2/Th17/Treg responses. LigiLactobacillus murinus (L. murinus) was enriched, while Bacteroides acidifaciens (B. acidifaciens) was diminished, SCFAs increased (acetate 2772.70 ± 21.08, propionate 669.84 ± 6.79, butyrate 324.14 ± 0.42 μg/g). Spearman correlations linked L. murinus to barrier proteins (ZO-1/Occludin/E-cadherin), contrasting B. acidifaciens–inflammation associations. These findings revealed that Pa JY062 exerted multi-target therapeutic effects on UC, and offered a wider array of options for intestinal health. Pa JY062 represents a promising natural antioxidant-based strategy for UC management.
Subjects
Author keywords
Authors and institutions
- Key Laboratory of Dairy Science, Ministry of Education, College of Food Science, Northeast Agricultural University, Harbin 150031, China.
- Food Laboratory of Zhongyuan, Luohe 462300, China.
Funding
- This research received financial backing from the Heilongjiang Provincial Natural Science Foun-dation Project
- Heilongjiang Provincial Natural Science Foundation Project
Cite
APA
Guo, J., Sun, Y., Gao, K., Zhao, H., Su, Y., Zhao, Y., Zhang, Y., & Jiang, Y. (2025). Lacticaseibacillus paracasei JY062 Postbiotic Alleviated 3% DSS-Induced Colitis in Mice via Integrated Antioxidant, Barrier Repair, Immunomodulatory and Microbiota Modulation. Antioxidants, 14(10), 1256. https://doi.org/10.3390/antiox14101256
Vancouver
Guo J, Sun Y, Gao K, Zhao H, Su Y, Zhao Y, et al. Lacticaseibacillus paracasei JY062 Postbiotic Alleviated 3% DSS-Induced Colitis in Mice via Integrated Antioxidant, Barrier Repair, Immunomodulatory and Microbiota Modulation. Antioxidants. 2025;14(10):1256. doi:10.3390/antiox14101256
BibTeX
@article{Guo2025,
author = {Guo, Jinfeng and Sun, Yilin and Gao, Kaiqi and Zhao, Haijie and Su, Yue and Zhao, Ying and Zhang, Yu and Jiang, Yujun},
title = {Lacticaseibacillus paracasei JY062 Postbiotic Alleviated 3% DSS-Induced Colitis in Mice via Integrated Antioxidant, Barrier Repair, Immunomodulatory and Microbiota Modulation},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {10},
pages = {1256},
doi = {10.3390/antiox14101256}
}
EUVIMED